Journal
DIABETOLOGIA
Volume 47, Issue 12, Pages 2129-2136Publisher
SPRINGER
DOI: 10.1007/s00125-004-1593-2
Keywords
CHD; HbA(1)c; hypertriglyceridaemia; lipoproteins; LDL cholesterol; non-HDL cholesterol; prospective studies; risk factors; type 2 diabetes; women
Categories
Funding
- NCI NIH HHS [CA87969] Funding Source: Medline
- NHLBI NIH HHS [HL65582, HL34594] Funding Source: Medline
- NIDDK NIH HHS [DK58845] Funding Source: Medline
Ask authors/readers for more resources
Aims/hypothesis. Non-HDL cholesterol ( the sum of LDL, VLDL and IDL cholesterol) is considered to be particularly valuable in the management of dyslipidaemia in type 2 diabetes. However, it remains uncertain whether the association between non-HDL cholesterol and cardiovascular risk in type 2 diabetes depends on the status of hyperglycaemia. We aimed to determine whether non-HDL cholesterol predicts CHD events among diabetic women independently of currently established risk factors and the status of glycaemic control. Methods. We prospectively followed 921 diabetic women in the Nurses' Health Study, who were free of cardiovascular disease at the time that blood was drawn in 1989/90. During 10 years of follow-up, we identified 122 incident CHD cases. Results. After adjustment for age, BMI, smoking, alcohol consumption, and other lifestyle risk factors, the multivariate relative risks (RRs) of CHD for extreme quartiles were 1.97 ( 95% CI: 1.14 - 3.43) for non-HDL cholesterol, 1.78 (1.02 - 3.11) for apolipoprotein B-100, and 1.93 ( 1.15 - 3.22) for LDL cholesterol. However, the association between non-HDL cholesterol and CHD risk was only apparent among women with elevated fasting triglycerides (RR for extreme quartiles: 3.80; p = 0.045). HbA(1)c was strongly associated with increased CHD risk ( RR for increase by 1 unit: 1.24; 95% CI: 1.13 - 1.35), and both non-HDL cholesterol and HbA1c additively predicted CHD risk ( RR for the combination of high non-HDL cholesterol and high HbA(1)c [tertiles]: 4.59). Conclusions/interpretation. Our study suggests that non-HDL cholesterol and HbA(1)c are potent predictors of CHD risk in diabetic women. Therapies to lower CHD risk in diabetic patients should emphasise both glycaemic control and lipid lowering.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available